Hallucinations in LLMs refer to instances where models generate plausible yet incorrect or unrelated information.
The US Food and Drug Administration (FDA) has approved the abbreviated new drug application (ANDA) of Lupin’s Sacubitril and ...
The FDA has extended the review period for the New Drug Application for elamipretide for the treatment of Barth syndrome.
An investigational higher dose of spinal muscular atrophy drug nusinersen gains attention as the FDA and European Medicines ...
The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date ...
Biogen (BIIB) announced that the U.S. Food and Drug Administration, FDA, has accepted the company’s supplemental New Drug Application, sNDA, ...
Atara Biotherapeutics’ layoffs could leave the biotech with around 80 employees. The cuts follow news that the FDA rejected ...
The FDA has approved a supplemental new drug application for Spravato, an esketamine nasal spray that can be used as ...
ITM's lutetium-containing therapy extended progression-free survival versus everolimus in patients with a specific kind of ...
Scientists have unveiled a groundbreaking method to test how thousands of active substances influence cellular metabolism ...